GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439–58.

Article  Google Scholar 

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–7.

Article  Google Scholar 

Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15:1138–47.

Article  CAS  PubMed  Google Scholar 

Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.

Article  CAS  PubMed  Google Scholar 

Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.

Article  CAS  PubMed  Google Scholar 

Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.

Article  CAS  PubMed  Google Scholar 

Tao C, Nogueira RG, Zhu Y, et al. Trial of endovascular treatment of acute basilar-artery occlusion. N Engl J Med. 2022;387:1361–72.

Article  PubMed  Google Scholar 

Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.

Article  PubMed  Google Scholar 

Liu L, Chen W, Zhou H, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke Vasc Neurol. 2020;5:159–76.

Article  PubMed  PubMed Central  Google Scholar 

Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–418.

Article  PubMed  Google Scholar 

Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke. J Neurointerv Surg. 2019;11:535–8.

Article  PubMed  Google Scholar 

Yang P, Zhang Y, Zhang L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke. N Engl J Med. 2020;382:1981–93.

Article  CAS  PubMed  Google Scholar 

Zi W, Qiu Z, Li F, et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial. JAMA. 2021;325:234–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suzuki K, Matsumaru Y, Takeuchi M, et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke: the SKIP randomized clinical trial. JAMA. 2021;325:244–53.

Article  PubMed  PubMed Central  Google Scholar 

Mitchell PJ, Yan B, Churilov L, et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 H of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet. 2022;400:116–25.

Article  CAS  PubMed  Google Scholar 

LeCouffe NE, Kappelhof M, Treurniet KM, et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke. N Engl J Med. 2021;385:1833–44.

Article  CAS  PubMed  Google Scholar 

Fischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104–15.

Article  CAS  PubMed  Google Scholar 

Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983–8.

Article  CAS  PubMed  Google Scholar 

Steger C, Pratter A, Martinek-Bregel M, et al. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke Registry. Eur Heart J. 2004;25:1734–40.

Article  PubMed  Google Scholar 

Bozzani A, Arici V, RagniIntravenous F, et al. thrombolysis before mechanical thrombectomy in patients with atrial fibrillation. J Neurointerv Surg. 2023;15(8): e9.

Article  PubMed  Google Scholar 

Stanton RJ, Eckman MH, Woo D, et al. Ischemic stroke and bleeding: clinical benefit of anticoagulation in atrial fibrillation after intracerebral hemorrhage. Stroke. 2020;51(3):808–14.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Turc G, Tsivgoulis G, Audebert HJ, et al. European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion. J Neurointerv Surg. 2022;14(3):209.

Article  PubMed  Google Scholar 

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

Article  PubMed  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp Clin Trials. 2015;45(Pt A):139–45.

Article  PubMed  PubMed Central  Google Scholar 

Cumpston M, Li TJ, Page MJ, Chandler J, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.

PubMed  Google Scholar 

Loo JH, Leow AS, Jing MX, et al. Impact of atrial fibrillation on the treatment effect of bridging thrombolysis in ischemic stroke patients undergoing endovascular thrombectomy: a multicenter international cohort study. J Neurointerv Surg. 2023;15(12):1274–9.

Article  PubMed  Google Scholar 

Lin LT, Blair C, Fu J, et al. Prior anticoagulation and bridging thrombolysis improve outcomes in patients with atrial fibrillation undergoing endovascular thrombectomy for anterior circulation stroke. J Neurointerv Surg. 2023;15(e3):e433–7.

Article  PubMed  Google Scholar 

Cao J, Xing PF, Zhu XC, et al. Mild and moderate cardioembolic stroke patients may benefit more from direct mechanical thrombectomy than bridging therapy: a subgroup analysis of a randomized clinical trial (DIRECT-MT). Front Neurol. 2022;24(13):1013819.

Article  Google Scholar 

Chen YX, Guo Y, Lin YN, et al. A comparative study between direct mechanical thrombectomy and bridging therapy in patients with atrial fibrillation associated anterior circulation large vessel occlusion stroke. Zhonghua Yi Xue Za Zhi. 2022;102(45):3630–3.

CAS  PubMed  Google Scholar 

Mujanovic A, Kurmann CC, Dobrocky T, et al. Bridging intravenous thrombolysis in patients with atrial fibrillation. Front Neurol. 2022;3(13): 945338.

Article  Google Scholar 

Akbik F, Alawieh A, Dimisko L, et al. Bridging thrombolysis in atrial fibrillation stroke is associated with increased hemorrhagic complications without improved outcomes. J Neurointerv Surg. 2022;14(10):979–84.

Article  PubMed  Google Scholar 

Yaghi S, Mistry E, Havenon AD, et al. Effect of alteplase use on outcomes in patients with atrial fibrillation: analysis of the initiation of anticoagulation after cardioembolic stroke study. J Am Heart Assoc. 2021;10(15): e020945.

Article  PubMed  PubMed Central  Google Scholar 

Chalos V, LeCouffe NE, Uyttenboogaart M, et al. Endovascular treatment with or without prior intravenous alteplase for acute ischemic stroke. J Am Heart Assoc. 2019;8(11): e011592.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaesmacher J, Dobrocky T, Heldner MR, et al. Systematic review and meta-analysis on outcome differences among patients with TICI2b versus TICI3 reperfusions: success revisited. J Neurol Neurosurg Psychiatry. 2018;89(9):910–7.

Article  PubMed  Google Scholar 

Guo YJ, Yang YQ, Zhou MK, et al. Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis. Stroke Vasc Neurol. 2018;3(4):203–8.

Article  PubMed  PubMed Central  Google Scholar 

Akbik F, Alawieh A, Cawley CM, et al. Differential effect of mechanical thrombectomy and intravenous thrombolysis in atrial fibrillation associated stroke. J Neurointerv Surg. 2021;13(10):883–8.

Article  PubMed  Google Scholar 

Zoppo GJD, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32(1):78–86.

Article  PubMed  Google Scholar 

Whitesell RT, Steenburg SD. Imaging findings of acute intravascular thrombus on non-enhanced computed tomography. Emerg Radiol. 2014;21:271–7.